STOCK TITAN
  1. Home
  2. ICPT

Intercept Pharmaceuticals (ICPT) Stock Price, News & Analysis

ICPT NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
30 252 sessions, November 14, 2022 to November 14, 2023
Largest daily move
+79.2% close of September 26, 2023
1-year change
+21% closing prices, November 14, 2022 to November 14, 2023
1-month change
+4.4% closing prices, October 13, 2023 to November 14, 2023

Company Description

ICPT has gained 21.0% over the past year. The last closing price was $19.00.

This page collects what Stock Titan holds for ICPT, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
+21%
Performance 1 year
-
Market Cap
-
Shares outstanding

Intercept Pharmaceuticals (ICPT) closed at $19.00 on November 14, 2023. Over the past 12 months, the price has gained 21.0%.

See what a $1,000 investment in ICPT would be worth today

Average down calculator for ICPT

ICPT Metrics & Rankings

Month to date
+0.4%
View ranking
YTD
+53.6%
View ranking

Price returns through November 14, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
—

Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference

—

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

clinical trial fda approval
0.00%

Intercept Announces New Phase 2 Data Showing Significant Impact of OCA-Bezafibrate Combination on Normalization of Multiple Key Biomarkers of PBC-Induced Liver Damage at AASLD The Liver Meeting® 2023

clinical trial
0.00%

Intercept Announces New Findings from Long-term Extension of Landmark POISE Trial in PBC Showing Importance of Biomarkers Beyond ALP at AASLD The Liver Meeting® 2023

0.00%

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

acquisition
0.00%

Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.

+0.64%

Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.

acquisition
+0.80%

Persephone Biosciences Appoints Daniel Bradbury as Chair of the Board of Directors

management
+0.54%

Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

+79.21%

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases

acquisition

Intercept Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include clinical trial, fda approval, acquisition, management. View all ICPT news →

SEC Filings

View All

No SEC filings available for ICPT.

Frequently Asked Questions

What is the current quoted price of Intercept Pharmaceuticals (ICPT)?

The current quoted price of Intercept Pharmaceuticals (ICPT) is $19 as of January 8, 2024.